Aldeyra Therapeutics (NASDAQ:ALDX) Upgraded to "Hold" by StockNews.com
StockNews.com upgraded shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a sell rating to a hold rating in a report issued on Wednesday. ALDX has been the topic of several other reports. Oppenheimer reaffirmed an outperform rating and issued a $14.00 price objective on shares of Aldeyra Therapeutics in a research report on Wednesday, […]